KaliVir Immunotherapeutics Strengthens Innovation Portfolio with Issuance of Three New U.S ...
PITTSBURGH--KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company developing cutting-edge, multi-mechanistic oncolytic viral immunotherapy programs, today announced the expansion of ...